📣 VC round data is live. Check it out!

Modular Medical Valuation Multiples

Discover revenue and EBITDA valuation multiples for Modular Medical and similar public comparables like Nova Eye Medical, NanoRepro, Finemedix, Medclair and more.

Modular Medical Overview

About Modular Medical

Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.


Founded

1998

HQ

United States

Employees

54

Financials (FY)

Revenue:
EBITDA: ($18M)

EV

$22M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Modular Medical Financials

Modular Medical reported last fiscal year revenue of — and negative EBITDA of ($18M).

In the same fiscal year, Modular Medical generated ($18M) in EBITDA losses and had net loss of ($19M).

Revenue (LTM)


Modular Medical P&L

In the most recent fiscal year, Modular Medical reported revenue of and EBITDA of ($18M).

Modular Medical is unprofitable as of last fiscal year, with EBITDA margin of — and net margin of —.

See analyst estimates for Modular Medical
Last FY202320242025202620272028
EBITDA($18M)($16M)($18M)($18M)
Net Profit($19M)($17M)($18M)($19M)

Financial data powered by Morningstar, Inc.

Modular Medical Stock Performance

Modular Medical has current market cap of $24M, and enterprise value of $22M.

Market Cap Evolution


Modular Medical's stock price is $4.50.

Modular Medical share price increased by 3.7% in the last 30 days, and by 423.3% in the last year.

Modular Medical has an EPS (earnings per share) of $-3.48.

See more trading valuation data for Modular Medical
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$22M$24M0.0%3.7%-39.3%423.3%$-3.48

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Modular Medical Valuation Multiples

Modular Medical trades at (1.2x) EV/EBITDA.

See NTM and 2027E valuation multiples for Modular Medical

EV / Revenue (LTM)


Modular Medical Financial Valuation Multiples

As of May 26, 2026, Modular Medical has market cap of $24M and EV of $22M.

Modular Medical has a P/E ratio of (1.3x).

Last FY202320242025202620272028
EV/EBITDA(1.2x)(1.3x)(1.2x)(1.2x)
EV/EBIT(1.2x)(1.3x)(1.2x)(1.2x)
P/E(1.3x)(1.5x)(1.3x)(1.3x)
EV/FCF(1.2x)(1.5x)(1.2x)(1.2x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Modular Medical Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Modular Medical Margins & Growth Rates

See estimated margins and future growth rates for Modular Medical

Modular Medical Growth Rates

23/2424/2526/2727/2828/29
EBITDA Growth9%1%
EBIT Growth12%2%
Net Profit Growth12%2%
FCF Growth18%4%

Data powered by FactSet, Inc. and Morningstar, Inc.

Modular Medical Operational KPIs

Modular Medical's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.4M for the same period.

Access forward-looking KPIs for Modular Medical
Last FY202620272028
Revenue per Employee$0.0M
Opex per Employee$0.4M

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Modular Medical Competitors

Modular Medical competitors include Nova Eye Medical, NanoRepro, Finemedix, Medclair, Biosynex, Harvard Bioscience, European Medical Solutions, Genomtec, Integrum and Genematrix.

Most Modular Medical public comparables operate across Medical Devices, HealthTech and DeepTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Nova Eye Medical1.2x1.1x(6.9x)(14.4x)
NanoRepro2.9x0.8x(4.0x)(12.0x)
Finemedix3.6x(23.2x)
Medclair4.2x21.4x
Biosynex0.8x62.5x
Harvard Bioscience0.7x0.7x7.7x7.5x
European Medical Solutions0.7x6.9x
Genomtec78638.0x(9.0x)

This data is available for Pro users. Sign up to see all Modular Medical competitors and their valuation data.

Start Free Trial

Modular Medical Funding History

Before going public, Modular Medical raised $4M in total equity funding, across 1 round.


Modular Medical Funding Rounds

DateStageRaised FromRaisedValuationRev. MultipleDeal Summary
Apr-19Seed$4MModular Medical raised $4.18 million in a Series A funding round on April 2, 2019. The company develops insulin delivery technologies, including the MODD1 insulin pump designed for low-cost operation and ease of use. A proprietary 2019 survey of U.S. healthcare payors indicated willingness for coverage at 20% discounts for products with specific features like no external controller and slim profile.

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Modular Medical

When was Modular Medical founded?Modular Medical was founded in 1998.
Where is Modular Medical headquartered?Modular Medical is headquartered in United States.
How many employees does Modular Medical have?As of today, Modular Medical has over 54 employees.
Who is the CEO of Modular Medical?Modular Medical's CEO is James E. Besser.
Is Modular Medical publicly listed?Yes, Modular Medical is a public company listed on Nasdaq.
What is the stock symbol of Modular Medical?Modular Medical trades under MODD ticker.
When did Modular Medical go public?Modular Medical went public in 2022.
Who are competitors of Modular Medical?Modular Medical main competitors include Nova Eye Medical, NanoRepro, Finemedix, Medclair, Biosynex, Harvard Bioscience, European Medical Solutions, Genomtec, Integrum, Genematrix.
What is the current market cap of Modular Medical?Modular Medical's current market cap is $24M.
Is Modular Medical profitable?No, Modular Medical is not profitable.
How many companies Modular Medical has acquired to date?Modular Medical hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Modular Medical has invested to date?Modular Medical hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Modular Medical

Lists including Modular Medical

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial